Reports for GLENMARK PHARMACEUTICALS CANADA INC.
Company Name
GLENMARK PHARMACEUTICALS CANADA INC.
Totals |
||
Shortage reports |
10 |
|
| Actual shortage: | 6 (60%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 4 (40%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS | 100MG 250MG | TABLET | Resolved | 2018-10-23 | 2019-01-12 | 65444 |
| GLN-ATOVAQUONE | 750MG | SUSPENSION | Resolved | 2024-08-29 | 2024-10-17 | 236216 |
| GLN-GABAPENTIN | 800MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-11-07 | 2024-12-02 | 242238 |
| GLN-OLMESARTAN HCTZ | 12.5MG 40MG | TABLET | Actual shortage | 2024-11-07 | 2024-11-18 | 242241 |
| GLN-OLMESARTAN HCTZ | 12.5MG 40MG | TABLET | Actual shortage | 2024-11-07 | 2024-11-18 | 242244 |
| GLN-OLMESARTAN HCTZ | 25MG 40MG | TABLET | Actual shortage | 2024-11-07 | 2024-11-18 | 242247 |
| GLN-URSODIOL | 250MG | TABLET | Actual shortage | 2024-11-07 | 2024-11-18 | 242232 |
| GLN-URSODIOL | 500MG | TABLET | Actual shortage | 2024-11-07 | 2024-11-18 | 242235 |
| GLN-URSODIOL | 250MG | TABLET | Resolved | 2017-11-28 | 2018-01-02 | 30985 |
| GLN-URSODIOL | 500MG | TABLET | Resolved | 2017-11-28 | 2018-01-02 | 30989 |
Showing 1 to 10 of 10
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0